{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T01:54:43Z","timestamp":1787018083686,"version":"build-2736575974"},"reference-count":19,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":["www.ahajournals.org"],"crossmark-restriction":true},"short-container-title":["Hypertension"],"published-print":{"date-parts":[[2010,4]]},"abstract":"<jats:p>\n                    Cardiac hypertrophy involves a remodeling process of the heart in response to diverse pathological stimuli. Both calcineurin\/nuclear factor of activated T cells pathway and microRNA-133 (\n                    <jats:italic>miR-133<\/jats:italic>\n                    ) have been shown to play a critical role in cardiac hypertrophy. It has been recognized that the expression and activity of calcineurin increases and\n                    <jats:italic>miR-133<\/jats:italic>\n                    expression decreases in the hypertrophic heart, and inhibition of calcineurin or increase of\n                    <jats:italic>miR-133<\/jats:italic>\n                    expression protects against cardiac hypertrophy. Here we tested the interaction between\n                    <jats:italic>miR-133<\/jats:italic>\n                    and calcineurin in cardiac hypertrophy. Cardiac hypertrophy in vivo and in vitro was induced by transverse aortic constriction and phenylephrine treatment. mRNA levels were measured by using real-time PCR methods. Luciferase assays showed that transfection of\n                    <jats:italic>miR-133<\/jats:italic>\n                    in HEK293 cells downregulated calcineurin expression, which was reversed by cotransfection with the\n                    <jats:italic>miR-133<\/jats:italic>\n                    \u2013specific 2\u2032-\n                    <jats:italic>O<\/jats:italic>\n                    -methyl antisense inhibitory oligoribonucleotides. These results were confirmed in cultured primary cardiomyocytes.\n                    <jats:italic>miR-133<\/jats:italic>\n                    expression was downregulated, and calcineurin activity was enhanced in both in vivo and in vitro cardiac hypertrophy models. Treatment of cells and animals with cyclosporin A, an inhibitor of calcineurin, prevented\n                    <jats:italic>miR-133<\/jats:italic>\n                    downregulation. Moreover, the antisense oligodeoxynucleotides against the catalytic subunits of calcineurin A\u03b2 and the decoy oligodeoxynucleotides targeting nuclear factor of activated T cells transcription factor, a calcineurin downstream effector, increased\n                    <jats:italic>miR-133<\/jats:italic>\n                    expression in cultured primary cardiomyocytes. Our data show that reciprocal repression between\n                    <jats:italic>miR-133<\/jats:italic>\n                    and calcineurin regulates cardiac hypertrophy.\n                  <\/jats:p>","DOI":"10.1161\/hypertensionaha.109.139519","type":"journal-article","created":{"date-parts":[[2010,2,22]],"date-time":"2010-02-22T22:47:13Z","timestamp":1266878833000},"page":"946-952","update-policy":"https:\/\/doi.org\/10.1161\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":126,"title":["Reciprocal Repression Between MicroRNA-133 and Calcineurin Regulates Cardiac Hypertrophy"],"prefix":"10.1161","volume":"55","author":[{"given":"De-Li","family":"Dong","sequence":"first","affiliation":[{"name":"From the Department of Pharmacology, Harbin Medical University, State-Province Key Laboratories of Biomedicine-Pharmaceutics of China, Harbin, People\u2019s Republic of China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chang","family":"Chen","sequence":"additional","affiliation":[{"name":"From the Department of Pharmacology, Harbin Medical University, State-Province Key Laboratories of Biomedicine-Pharmaceutics of China, Harbin, People\u2019s Republic of China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rong","family":"Huo","sequence":"additional","affiliation":[{"name":"From the Department of Pharmacology, Harbin Medical University, State-Province Key Laboratories of Biomedicine-Pharmaceutics of China, Harbin, People\u2019s Republic of China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ning","family":"Wang","sequence":"additional","affiliation":[{"name":"From the Department of Pharmacology, Harbin Medical University, State-Province Key Laboratories of Biomedicine-Pharmaceutics of China, Harbin, People\u2019s Republic of China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhe","family":"Li","sequence":"additional","affiliation":[{"name":"From the Department of Pharmacology, Harbin Medical University, State-Province Key Laboratories of Biomedicine-Pharmaceutics of China, Harbin, People\u2019s Republic of China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-Jie","family":"Tu","sequence":"additional","affiliation":[{"name":"From the Department of Pharmacology, Harbin Medical University, State-Province Key Laboratories of Biomedicine-Pharmaceutics of China, Harbin, People\u2019s Republic of China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun-Tao","family":"Hu","sequence":"additional","affiliation":[{"name":"From the Department of Pharmacology, Harbin Medical University, State-Province Key Laboratories of Biomedicine-Pharmaceutics of China, Harbin, People\u2019s Republic of China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xia","family":"Chu","sequence":"additional","affiliation":[{"name":"From the Department of Pharmacology, Harbin Medical University, State-Province Key Laboratories of Biomedicine-Pharmaceutics of China, Harbin, People\u2019s Republic of China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Huang","sequence":"additional","affiliation":[{"name":"From the Department of Pharmacology, Harbin Medical University, State-Province Key Laboratories of Biomedicine-Pharmaceutics of China, Harbin, People\u2019s Republic of China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bao-Feng","family":"Yang","sequence":"additional","affiliation":[{"name":"From the Department of Pharmacology, Harbin Medical University, State-Province Key Laboratories of Biomedicine-Pharmaceutics of China, Harbin, People\u2019s Republic of China."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"e_1_3_2_1_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0092-8674(04)00045-5"},{"key":"e_1_3_2_2_2","doi-asserted-by":"publisher","DOI":"10.1038\/nm1582"},{"key":"e_1_3_2_3_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0608791103"},{"key":"e_1_3_2_4_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.res.0000257913.42552.23"},{"key":"e_1_3_2_5_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.1139089"},{"key":"e_1_3_2_6_2","doi-asserted-by":"publisher","DOI":"10.1038\/nature07511"},{"key":"e_1_3_2_7_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0092-8674(00)81573-1"},{"key":"e_1_3_2_8_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0008-6363(02)00661-2"},{"key":"e_1_3_2_9_2","doi-asserted-by":"publisher","DOI":"10.1161\/circ.101.20.2431"},{"key":"e_1_3_2_10_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.cir.0000016044.19527.96"},{"key":"e_1_3_2_11_2","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.C700015200"},{"key":"e_1_3_2_12_2","doi-asserted-by":"publisher","DOI":"10.1210\/en.2006-1324"},{"key":"e_1_3_2_13_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.97.3.1196"},{"key":"e_1_3_2_14_2","doi-asserted-by":"publisher","DOI":"10.1016\/0169-328X(96)00094-0"},{"key":"e_1_3_2_15_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0306-4522(00)00161-5"},{"key":"e_1_3_2_16_2","doi-asserted-by":"publisher","DOI":"10.1161\/res.87.12.e61"},{"key":"e_1_3_2_17_2","doi-asserted-by":"publisher","DOI":"10.1128\/MCB.25.15.6649-6659.2005"},{"key":"e_1_3_2_18_2","doi-asserted-by":"publisher","DOI":"10.1002\/jcp.20916"},{"key":"e_1_3_2_19_2","doi-asserted-by":"publisher","DOI":"10.1093\/cvr\/cvn181"}],"container-title":["Hypertension"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ahajournals.org\/doi\/full\/10.1161\/HYPERTENSIONAHA.109.139519","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,13]],"date-time":"2024-05-13T05:32:47Z","timestamp":1715578367000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ahajournals.org\/doi\/10.1161\/HYPERTENSIONAHA.109.139519"}},"subtitle":["A Novel Mechanism for Progressive Cardiac Hypertrophy"],"short-title":[],"issued":{"date-parts":[[2010,4]]},"references-count":19,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2010,4]]}},"alternative-id":["10.1161\/HYPERTENSIONAHA.109.139519"],"URL":"https:\/\/doi.org\/10.1161\/hypertensionaha.109.139519","relation":{},"ISSN":["0194-911X","1524-4563"],"issn-type":[{"value":"0194-911X","type":"print"},{"value":"1524-4563","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,4]]},"assertion":[{"value":"2009-07-19","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2010-01-22","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2010-02-22","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}